This is a continuation of a long topic, addressed by post number rather than by page. Start at post 1 · go to the accepted answer.
Precision of home tests: most consumer-accessible devices are not precise to the level people want ("is this 99% pure or 97% pure"). They give a yes/no or a rough category, not a quantitative number.
Lateral-flow devices: like a rapid COVID test. They have a reagent strip and produce a colour result. They are quick but not precise and not intended for quantitative work.
Picking up post #60: that is the part I would want checked first.
What you can use home tests for: confirmation that a solution contains peptide (as opposed to being saline alone), rough screening for very different compounds (semaglutide versus totally unrelated compound). What you cannot use them for: precise purity assessment or verification that the identity is correct.
Coming back to post #62, because the follow-up matters more than the original answer.
Two things before anyone answers the substance.
First, the context in the first post is clear and specific. Second, the question is framed so that an answer can actually address it. Both are the norm here and both matter more than they sound.
post #64 is right about the mechanism and I think understates the practical bit.
False positives and false negatives: no test has 100% sensitivity and 100% specificity. A negative result does not guarantee absence; a positive result does not guarantee presence. The predictive value depends on prevalence.
What you can use home tests for: confirmation that a solution contains peptide (as opposed to being saline alone), rough screening for very different compounds (semaglutide versus totally unrelated compound). What you cannot use them for: precise purity assessment or verification that the identity is correct.
For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
I read post #66 twice before replying, because I had assumed the opposite.
Colorimetric tests: colour intensity correlates with concentration, but the relationship is non-linear at extremes and the correlation depends on the exact conditions (pH, temperature, timing). Reading the colour visually introduces subjectivity.
post #68 answers the question as asked. The question underneath it is different.
Immunoassay limitations: tests that use antibodies have cross-reactivity limitations. An antibody raised to semaglutide will cross-react to some degree with tirzepatide and other structurally similar compounds. The test result conflates them.
On post #66 — agreed on the reasoning, with one qualification.
Two things before anyone answers the substance.
First, the context in the first post is clear and specific. Second, the question is framed so that an answer can actually address it. Both are the norm here and both matter more than they sound.
Two things before anyone answers the substance.
First, the context in the first post is clear and specific. Second, the question is framed so that an answer can actually address it. Both are the norm here and both matter more than they sound.
Sample handling matters: if a sample is contaminated or degraded before testing, the test gives you the result for the degraded sample, not for fresh material. That is not a failure of the test; it is the test working correctly.
Worth separating two things that post #69 runs together.
Enzyme assays: if you have an enzyme that reacts specifically with your compound, an enzyme-based assay can work. These are sometimes available commercially but are less common than antibody-based tests.
Molecular tests: DNA or RNA tests are not applicable to peptides, which do not contain nucleic acids. Peptide-specific tests rely on protein recognition, not nucleic-acid detection.
Precision of home tests: most consumer-accessible devices are not precise to the level people want ("is this 99% pure or 97% pure"). They give a yes/no or a rough category, not a quantitative number.
On post #73 — agreed on the reasoning, with one qualification.
Why third-party testing is stronger: a home test run by the person who made the compound is a self-selected result. The test run by a neutral third party removes obvious sources of bias.
post #77 answers the question as asked. The question underneath it is different.
I disagree with the reply above, and I think the disagreement is substantive rather than terminological.
The distinction being drawn does not survive when you look at the published data for this specific question. I would be glad to be shown wrong on this, because the version I am arguing against is more convenient.
I read post #77 twice before replying, because I had assumed the opposite.
What physical quantity does the device measure? A colorimetric or lateral-flow method typically responds to a class of chemistry rather than to a specific molecule. It can distinguish "peptide present" from "nothing present" but generally cannot distinguish the intended peptide from a closely related one.
This follows post #77 rather than contradicting it.
Molecular tests: DNA or RNA tests are not applicable to peptides, which do not contain nucleic acids. Peptide-specific tests rely on protein recognition, not nucleic-acid detection.
Picking up post #78: that is the part I would want checked first.
Why third-party testing is stronger: a home test run by the person who made the compound is a self-selected result. The test run by a neutral third party removes obvious sources of bias.
Precision of home tests: most consumer-accessible devices are not precise to the level people want ("is this 99% pure or 97% pure"). They give a yes/no or a rough category, not a quantitative number.
What physical quantity does the device measure? A colorimetric or lateral-flow method typically responds to a class of chemistry rather than to a specific molecule. It can distinguish "peptide present" from "nothing present" but generally cannot distinguish the intended peptide from a closely related one.
Colorimetric tests: colour intensity correlates with concentration, but the relationship is non-linear at extremes and the correlation depends on the exact conditions (pH, temperature, timing). Reading the colour visually introduces subjectivity.
Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the kind that comes from remembering a figure instead of looking it up.
Worth separating two things that post #84 runs together.
Lateral-flow devices: like a rapid COVID test. They have a reagent strip and produce a colour result. They are quick but not precise and not intended for quantitative work.
Sample handling matters: if a sample is contaminated or degraded before testing, the test gives you the result for the degraded sample, not for fresh material. That is not a failure of the test; it is the test working correctly.
False positives and false negatives: no test has 100% sensitivity and 100% specificity. A negative result does not guarantee absence; a positive result does not guarantee presence. The predictive value depends on prevalence.
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
What I would want from a home test that does not exist yet — what changed since
Asking directly, because I could not find a straight answer: What I would want from a home test that does not exist yet — what changed since Posting the method first, because I know what the first three…
|
+101 | 111 | 1.9k | 21h |
|
Why quantitation is the hard part, not detection
Why quantitation is the hard part, not detection I have a specific reason for asking rather than idle curiosity, and the context is below. Posting the method first, because I know what the first three replies…
|
+11 | 15 | 27k | 12mo |
|
Second pass at: Cost versus information: making the trade-off explicitly
Posting this under the heading it deserves: Second pass at: Cost versus information: making the trade-off explicitly Everything below is what sits behind that. Working through the identity arithmetic and I…
|
+23 | 27 | 6.1k | 22h |
|
Reading a home test result without over-claiming — what changed since
On the subject in the title: Reading a home test result without over-claiming — what changed since Working notes rather than a conclusion. Working through the identity arithmetic and I would like it checked.…
|
2 | 12k | 6mo | |
|
What consumer-accessible tests can and cannot determine — a second dataset
What consumer-accessible tests can and cannot determine — a second dataset I have a specific reason for asking rather than idle curiosity, and the context is below. Posting the method first, because I know…
|
+117 | 131 | 45k | 10h |
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Specificity, linearity, accuracy, precision, range, robustness — with real criteria — a second dataset
On the subject in the title: Specificity, linearity, accuracy, precision, range, robustness — with real criteria — a second dataset Working notes rather than a conclusion. Working through the identity…
|
+53 | 58 | 7.5k | 6mo |
|
Repeatability versus intermediate precision
Repeatability versus intermediate precision — setting out what I have, and where I think it stops being reliable. Posting the method first, because I know what the first three replies will otherwise be.…
|
+119 | 134 | 34k | 13mo |
|
What a stability-indicating method is and how you demonstrate one
Asking directly, because I could not find a straight answer: What a stability-indicating method is and how you demonstrate one Working through the identity arithmetic and I would like it checked. retatrutide…
|
4 | 57k | 6mo | |
|
A supplier that answers analytical questions with restated claims
On the subject in the title: A supplier that answers analytical questions with restated claims Working notes rather than a conclusion. A logistics question, since the answers here are usually better than…
|
+107 | 118 | 45k | 12mo |
|
Documentation that appears only after payment
Documentation that appears only after payment Writing it up because I had to work it out twice and would rather nobody else did. I would like to talk about documentation quality as a signal, separately from…
|
+113 | 124 | 13k | 7mo |